Clinical Trials
Web
Site
Search
Saturday, July 05, 2008
..::
Clinical Trials
::..
Register
Login
Clinical Trials
View All Recent Entries
All Programs
BMT
Breast
Cutaneous
Gastrointestinal
Genitourinary
Gynecologic Oncology
Head & Neck
Malignant Hematology
Neuro-Oncology
Pediatric
Sarcoma
Thoracic
Search Trials
All
All Programs
BMT
Breast
Cutaneous
Gastrointestinal
Genitourinary
Gynecologic Oncology
Head & Neck
Malignant Hematology
Neuro-Oncology
Pediatric
Sarcoma
Thoracic
Keywords
Phrase
Archives
Study Number:
Search
Head & Neck
Category:
Head & Neck
Created:
1/2/2007 11:37 AM
Head & Neck
Head & Neck (100806)
Sponsor: MUSC (100806)
By Head & Neck on
7/5/2008 10:00 AM
CT Perfusion in Head and Neck Cancer
None Available
More...
Head & Neck (100838)
Sponsor: MUSC (100838)
By Head & Neck on
7/5/2008 10:00 AM
A Phase II Study of Gemcitabine in Combination with Doxorubicin for Patients with Head and Neck Cancer
HIPAA Authorization
Informed Consent - Intervention
Protocol
More...
Head & Neck (100949)
Sponsor: Genentech ()
By Head & Neck on
7/5/2008 10:00 AM
Multicenter Randomized Phase II Study of Erlotinib, Cisplatin and Radiotherapy Vs Cisplatin and Radiotherapy in Patients with Stage III and IV Squamous Cell Carcinoma of the Head and Neck
HIPAA Authorization
Informed Consent - Intervention
Protocol
More...
Head & Neck (100955)
Sponsor: CTSU/ECOG (E1302)
By Head & Neck on
7/5/2008 10:00 AM
Phase III Randomized, Placebo Controlled, Trial of Docetaxel Versus Docetaxel Plus ZD1839 (Iressa, Gefitinib) in Performance Status 2 or Previously Treated Patients with Recurrent or Metastatic Head and Neck Cancer
HIPAA Authorization
Informed Consent
Informed Consent
Informed Consent - Intervention
Protocol
More...
Head & Neck (101037)
Sponsor: Amgen, Inc. ()
By Head & Neck on
7/5/2008 10:00 AM
A Randomized, Open-Label, Controlled, Phase II Trial of Combination Chemotherapy with or without Panitumumab as First-line Treatment of Subjects with Metastatic or Recurrent Head and Neck Cancer, and Cross-over Second-line Panitumumab Monotherapy of Subjects who Fail the Combination Chemotherapy Only Arm
HIPAA Authorization
Informed Consent - Intervention
Informed Consent - Tissue
Protocol
More...
Head & Neck (101040)
Sponsor: DoD ()
By Head & Neck on
7/5/2008 10:00 AM
Respiratory-Gated PET/CT for Evaluation of the Small (4-10 mm) Indeterminate Pulmonary Nodule
None Available
More...
Head & Neck (101043)
Sponsor: Astra Zeneca (D2400C00058)
By Head & Neck on
7/5/2008 10:00 AM
An International, Phase II, Randomied, Double-Blinded, Placebo-Controlled, Multi-Center Study to Assess the Efficacy of ZD6474 (ZACTIMA) versus Placebo in Subjects with Unresectable Locally Advanced or Metastatic Medullary Thyroid Cancer
HIPAA Authorization
Informed Consent
Informed Consent-Biomarker
Protocol
More...
Head & Neck (101132)
Sponsor: MUSC (101132)
By Head & Neck on
7/5/2008 10:00 AM
CYP1B1 Induction In Tobacco-Related Oral Carcinogenesis
None Available
More...
Head & Neck (101148)
Sponsor: RTOG (0615)
By Head & Neck on
7/5/2008 10:00 AM
A Phase II Study Of Concurrent Chemoradiotherapy Using Three-Dimensional Conformal Radiotherapy (3d-Crt) Or Intensity-Modulated Radiation Therapy (Imrt) + Bevacizumab (Bv) For Locally Or Regionally Advanced Nasopharyngeal Cancer
HIPAA Authorization
Informed Consent
Protocol
More...
Squamous Cell (101000)
Sponsor: VA (101000)
By Head & Neck on
7/5/2008 10:00 AM
Vitamin D Differentiation-Inducing Therapy to Enhance Intratumoral Anti-Tumor Immune Reactivity
HIPAA Authorization
Informed Consent - Intervention
Protocol
More...
Copyright 2007 by Hollings Cancer Center
Terms Of Use
Privacy Statement